Nikunj Satani

12PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsMolecular targetsNeural engineeringRespiratory diseasesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 17, 2023
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.

Victoria C Yan, Yasaman Barekatain, Yu-Hsi Lin

|Oct 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.

Victoria C Yan, Cong-Dat Pham, Elliot S Ballato

|Jul 10, 2021
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.

Yasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan

|Nov 24, 2020
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi

|Aug 18, 2020
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes.

Nikunj Satani, Kaavya Giridhar, Chunyan Cai

Pageof 2